Application of ginsenoside Rg6 in preparation of medicine for preventing and treating PTSD
The invention discloses an application of ginsenoside Rg6 in preparation of a medicine for preventing and treating PTSD, and provides a medicine containing the ginsenoside Rg6 for preventing and treating PTSD, the ginsenoside Rg6 can be used as a single-component medicine and can also be used as a c...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses an application of ginsenoside Rg6 in preparation of a medicine for preventing and treating PTSD, and provides a medicine containing the ginsenoside Rg6 for preventing and treating PTSD, the ginsenoside Rg6 can be used as a single-component medicine and can also be used as a component in a medicine composition, and the medicine composition can be used as a medicine for preventing and treating PTSD. The dosage form of the medicine containing ginsenoside Rg6 is one of tablets, capsules, granules, pills, a suspending agent, a solution and an injection. The invention proves that the ginsenoside Rg6 has the efficacy of resisting PTSD-like behaviors.
本发明公开了人参皂苷Rg6在制备防治PTSD药物中的应用,同时提供了含有人参皂苷Rg6的防治PTSD药物,所述人参皂苷Rg6可作为单一成分药物使用,也可作为药物组合物中的一个成分使用,所述的含有人参皂苷Rg6的药物剂型为片剂、胶囊、颗粒剂、丸剂、悬浮剂、溶液、注射剂中的一种。本发明证实了人参皂苷Rg6具有抗PTSD样行为药效。 |
---|